A patient developed malignant atrophic papulosis with only cutaneous manifestation. Repeated coloscopy uncovered no malignant papules in the colon. Referring to the literature, the value of permanent anticoagulant therapy is discussed. In contrast to the term "malignant" atrophic papulosis, there also seems to be a variant with a benign clinical course.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s105-002-8047-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tumor necrosis factor ALPHA Inhibitor Associated Köhlmeier-Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis.
Am J Dermatopathol
September 2024
Sanders Dermatology, New City, NY.
Article Synopsis
- Malignant atrophic papulosis, also known as Köhlmeier-Degos disease, was first identified in 1941 and is characterized by skin rashes and serious intestinal issues, including perforations.
- This disease involves unique vascular damage affecting microvasculature and arteries, leading to distinctive skin lesions and changes in blood vessel structure.
- A case study highlights the emergence of Köhlmeier-Degos disease following treatment with a TNF-alpha inhibitor (golimumab), exploring the relationship between TNF-alpha and type I interferon signaling in the disease's progression.
Case Report: Infant-onset Degos disease with nervous system involvement and a literature review.
Front Pediatr
July 2024
Department of Rheumatology, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Article Synopsis
- Degos disease, or malignant atrophic papulosis (MAP), is an autoinflammatory condition that primarily impacts small- to medium-sized arteries.
- It most frequently affects the gastrointestinal and nervous systems.
- The report discusses a specific case where Degos disease began in infancy, leading to significant neurological complications.
Clinical Manifestation of Degos Disease: Painful Penile Ulcers.
Cutis
April 2024
Baylor Scott & White Health Central Texas Foundation, Temple.
Degos disease: A rare disease with a fatal outcome.
Med Clin (Barc)
August 2024
Emergency Physician, Hospital Santa Lucia, Cartagena, Spain.
Malignant atrophic papulosis treated with eculizumab and hirudin: a fatal case report and literature review.
Front Cardiovasc Med
March 2024
Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, China.
Article Synopsis
- Malignant atrophic papulosis (MAP) is a rare vascular disease with no known cause or established treatment, affecting multiple body systems, particularly the gastrointestinal tract and central nervous system; it generally has a poor prognosis.
- A case study of a 20-year-old male with MAP showed severe symptoms like abdominal pain, bowel perforation, and abscesses, and he was treated with various medications and surgeries but ultimately died within five months.
- The study emphasizes the need for early surgical evaluation and aggressive treatment options like eculizumab and treprostinil for patients with MAP to improve survival rates, particularly those with abdominal symptoms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!